In ₹ Crore except Per Share Latest Annual | KRSNAA FY26 | SURAKSHA FY26 | HEALTHX FY26 | NEPHROPLUS FY26 | Peer Median | |
|---|---|---|---|---|---|---|
| Valuation — at last close | ||||||
| P/E | ◆ 18.00× | 52.78× | 824.32× | 88.35× | 88.35× -80% | |
| P/B | 1.86× | 6.98× | ◆ 1.27× | 6.73× | 6.73× -72% | |
| EV/EBITDA | ◆ 11.01× | 17.79× | — | 32.18× | 24.98× -56% | |
| Market Cap | ₹1,828 Cr | ₹1,699 Cr | ₹970 Cr | ₹7,517 Cr | ₹1,699 Cr +8% | |
| Growth | ||||||
| Revenue CAGR 3Y | ◆ 16.63% | — | 8.26% | — | 8.26% +101% | |
| Revenue CAGR 5Y | — | — | 19.20% | — | 19.20% | |
| Net Income CAGR 3Y | 17.76% | — | — | — | — | |
| Revenue YoY (latest Q) | 22.05% | 20.75% | ◆ 49.73% | — | 35.24% -37% | |
| Net Income YoY (latest Q) | -19.34% | ◆ 40.00% | -92.53% | — | -26.27% +26% | |
| Profitability | ||||||
| EBITDA Margin | 27.42% | ◆ 30.73% | -3.95% | 22.72% | 22.72% +21% | |
| Net Income Margin | ◆ 13.13% | 10.12% | -0.11% | 7.69% | 7.69% +71% | |
| Return on Common Equity | 10.35% | ◆ 13.22% | 0.15% | 6.88% | 6.88% +50% | |
| Return on Capital Employed | 7.84% | ◆ 13.89% | — | 11.63% | 12.76% -39% | |
| Return on Assets | 5.56% | ◆ 7.01% | -0.15% | 5.22% | 5.22% +7% | |
| Credit & Quality | ||||||
| Total Debt/Equity | 0.55× | ◆ 0.01× | — | 0.07× | 0.04× +1275% | |
| Interest Coverage | 3.53× | ◆ 4.30× | -75.12× | 2.26× | 2.26× +56% | |
| Scale — latest FY | ||||||
| Revenue / Total Income | ₹773 Cr | ₹310 Cr | ₹1,319 Cr | ₹999 Cr | ₹999 Cr -23% | |
| Net Income | ₹101 Cr | ₹31.4 Cr | −₹1.4 Cr | ₹76.8 Cr | ₹31.4 Cr +223% | |
| Total Assets | ₹1,824 Cr | ₹448 Cr | ₹936 Cr | ₹1,471 Cr | ₹936 Cr +95% | |
| EPS | ₹31.3 | ₹6.18 | ₹0.37 | ₹8.48 | ₹6.18 +406% | |
| Book Value per Share | ₹302.23 | ₹46.75 | ₹240.57 | ₹111.27 | ₹111.27 +172% | |